Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation

Fang Shao,Jie Pan,Yewen Xie,Jun Ding,Xiao Sun,Lei Xia,Dawei Zhu,Shizhong Wang,Chunjian Qi,Fang ShaoJie PanYewen XieJun DingXiao SunLei XiaDawei ZhuShizhong WangChunjian QiMedical Research Center,the Affiliated Changzhou Second People's Hospital of Nanjing Medical University,Changzhou,P. R. China
DOI: https://doi.org/10.1080/01635581.2023.2274622
2023-10-29
Nutrition and Cancer
Abstract:Sulforaphane (SFN) is a compound derived from cruciferous plants. It has received considerable attention in recent years due to its effectiveness in cancer prevention and anti-inflammatory properties. The purpose of this study was to evaluate the antitumor potential of sulforaphane on colitis-associated carcinogenesis (CAC) through the establishment of a mouse model with AOM/DSS. First, AOM/DSS and DSS-induced model were established and administered SFN for 10 wk, and then the severity of colitis-associated colon cancer was examined macroscopically and histologically. Subsequently, immune cells and cytokines in the tumor microenvironment (TME) were quantified. Finally, the influence of sulforaphane was also investigated using different colon cell lines. We found that sulforaphane treatment decreased tumor volume, myeloid-derived suppressor cells (MDSC) expansion, the expression of the proinflammatory cytokine IL-1β, and the level of IL-10 in serum. Also, it enhanced the antitumor activities of CD8+ T cells and significantly reduced tumorigenesis as induced by AOM/DSS. SFN also attenuated intestinal inflammation in DSS-induced chronic colitis by reshaping the inflammatory microenvironment. This work demonstrates that sulforaphane suppresses carcinogenesis-associated intestinal inflammation and prevents AOM/DSS-induced intestinal tumorigenesis and progression.
oncology,nutrition & dietetics
What problem does this paper attempt to address?